JP2015504098A5 - - Google Patents

Download PDF

Info

Publication number
JP2015504098A5
JP2015504098A5 JP2014553507A JP2014553507A JP2015504098A5 JP 2015504098 A5 JP2015504098 A5 JP 2015504098A5 JP 2014553507 A JP2014553507 A JP 2014553507A JP 2014553507 A JP2014553507 A JP 2014553507A JP 2015504098 A5 JP2015504098 A5 JP 2015504098A5
Authority
JP
Japan
Prior art keywords
drug delivery
delivery material
composite drug
material according
coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014553507A
Other languages
English (en)
Japanese (ja)
Other versions
JP6282231B2 (ja
JP2015504098A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/022466 external-priority patent/WO2013112434A1/en
Publication of JP2015504098A publication Critical patent/JP2015504098A/ja
Publication of JP2015504098A5 publication Critical patent/JP2015504098A5/ja
Application granted granted Critical
Publication of JP6282231B2 publication Critical patent/JP6282231B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014553507A 2012-01-23 2013-01-22 固化するデポー形成の注入可能な薬物製剤に懸濁される持続放出された生分解性または生体侵食性微小球または微小粒子 Expired - Fee Related JP6282231B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261589681P 2012-01-23 2012-01-23
US61/589,681 2012-01-23
PCT/US2013/022466 WO2013112434A1 (en) 2012-01-23 2013-01-22 Time released biodegradable or bioerodible microspheres or microparticles suspended in a solidifying depot-forming injectable drug formulation

Publications (3)

Publication Number Publication Date
JP2015504098A JP2015504098A (ja) 2015-02-05
JP2015504098A5 true JP2015504098A5 (enExample) 2016-03-10
JP6282231B2 JP6282231B2 (ja) 2018-02-21

Family

ID=47630595

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014553507A Expired - Fee Related JP6282231B2 (ja) 2012-01-23 2013-01-22 固化するデポー形成の注入可能な薬物製剤に懸濁される持続放出された生分解性または生体侵食性微小球または微小粒子

Country Status (17)

Country Link
US (5) US20130189369A1 (enExample)
EP (1) EP2806853B1 (enExample)
JP (1) JP6282231B2 (enExample)
KR (5) KR20230104761A (enExample)
CN (1) CN104136006B (enExample)
AU (3) AU2013212583A1 (enExample)
BR (1) BR112014017969A8 (enExample)
CA (1) CA2861348C (enExample)
DK (1) DK2806853T3 (enExample)
ES (1) ES2821526T3 (enExample)
HU (1) HUE050904T2 (enExample)
IL (2) IL233620A0 (enExample)
MX (1) MX364864B (enExample)
NZ (1) NZ627368A (enExample)
RU (1) RU2672596C2 (enExample)
WO (1) WO2013112434A1 (enExample)
ZA (1) ZA201405091B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013212583A1 (en) * 2012-01-23 2014-08-14 Allergan, Inc. Time released biodegradable or bioerodible microspheres or microparticles suspended in a solidifying depot-forming injectable drug formulation
US20150335704A1 (en) * 2014-05-23 2015-11-26 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions comprising gels and methods for fabricating thereof
US20170112936A1 (en) * 2014-05-23 2017-04-27 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions comprising gels and methods for fabricating thereof
CN104306330A (zh) * 2014-09-24 2015-01-28 万特制药(海南)有限公司 一种盐酸美金刚缓释混悬液及其制备方法
CA2998504C (en) 2015-09-21 2023-06-20 Teva Pharmaceuticals International Gmbh Sustained release olanzapine formulations
KR20180102069A (ko) 2015-11-12 2018-09-14 그레이버그 비젼, 인크. 요법을 위한 응집성 마이크로입자
JP7051721B2 (ja) 2016-06-30 2022-04-11 デュレクト コーポレーション デポー製剤
US10682340B2 (en) 2016-06-30 2020-06-16 Durect Corporation Depot formulations
US10646443B2 (en) 2017-03-20 2020-05-12 Teva Pharmaceuticals International Gmbh Sustained release olanzapine formulations
MX2019013363A (es) 2017-05-10 2020-01-13 Graybug Vision Inc Microparticulas de liberacion extendida y suspensiones de las mismas para terapia medica.
BR112020000506A2 (pt) * 2017-07-11 2020-07-14 Sustained Nano Systems Llc formulações farmacêuticas hipercomprimidas
CN107595765A (zh) * 2017-09-22 2018-01-19 沈阳兴齐眼药股份有限公司 一种眼用缓释药物递送系统及其制备方法
GB2586975B (en) * 2019-09-09 2024-03-06 Roemex Ltd Device and method for use with subsea pipelines
WO2022153262A1 (en) 2021-01-18 2022-07-21 Anton Frenkel Pharmaceutical dosage form
WO2022198167A1 (en) * 2021-03-15 2022-09-22 Oakwood Laboratories, Llc Microsphere formulations comprising naltrexone and methods for making and using the same
US20240277654A1 (en) 2021-07-06 2024-08-22 Mark Hasleton Treatment of serotonin reuptake inhibitor withdrawal syndrome
CN116869914A (zh) * 2023-05-30 2023-10-13 庄秉谚 无针注射系统的投递物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
DK0754032T3 (da) * 1994-04-08 2002-04-02 Atrix Lab Inc Flydende frigivelsessammensætninger
CA2275587C (en) * 1996-12-20 2006-10-24 Alza Corporation Injectable depot gel composition and method of preparing the composition
US6589549B2 (en) * 2000-04-27 2003-07-08 Macromed, Incorporated Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
GB0122318D0 (en) * 2001-09-14 2001-11-07 Novartis Ag Organic compounds
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
CN1314452C (zh) * 2002-04-22 2007-05-09 沈阳药科大学 具有适宜相转变温度的眼用原位凝胶制剂
US20060039979A1 (en) * 2002-12-04 2006-02-23 Kazuhito Yamada Drug delivery system using subconjunctival depot
US20090148527A1 (en) * 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
US20060182781A1 (en) * 2004-04-30 2006-08-17 Allergan, Inc. Methods for treating ocular conditions with cyclic lipid contraining microparticles
US7893040B2 (en) * 2005-07-22 2011-02-22 Oculis Ehf Cyclodextrin nanotechnology for ophthalmic drug delivery
US20070202186A1 (en) * 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
CA2691597C (en) * 2007-06-25 2016-04-05 Otsuka Pharmaceutical Co., Ltd. Microspheres having core/shell structure
KR20120095371A (ko) * 2009-10-01 2012-08-28 에보닉 데구사 코포레이션 노화 황반변성 치료용 극미립자 조성물들 및 노화 황반변성 치료방법
CN101816627B (zh) * 2010-04-16 2012-03-07 浙江大学 一种协同治疗型多物质缓释滴眼剂及制备方法
CN102100663B (zh) * 2011-01-14 2013-04-17 华南理工大学 一种pH敏感型原位凝胶纳米缓释眼药水的制备方法
AU2013212583A1 (en) * 2012-01-23 2014-08-14 Allergan, Inc. Time released biodegradable or bioerodible microspheres or microparticles suspended in a solidifying depot-forming injectable drug formulation

Similar Documents

Publication Publication Date Title
JP2015504098A5 (enExample)
RU2014134420A (ru) Биологически разлагаемые или биологически разрушаемые микросферы или микрочастицы длительного высвобождения, суспендированные в затвердевающем депообразующем инъекцируемом лекарственном составе
Ding et al. Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics
Mottaghitalab et al. Silk fibroin nanoparticle as a novel drug delivery system
De Cicco et al. Prilling and supercritical drying: A successful duo to produce core-shell polysaccharide aerogel beads for wound healing
Chen et al. Preparation, properties and challenges of the microneedles-based insulin delivery system
Jubeli et al. E-selectin as a target for drug delivery and molecular imaging
Rattanakit et al. Extrusion printed polymer structures: a facile and versatile approach to tailored drug delivery platforms
Mao et al. Recent advances in polymeric microspheres for parenteral drug delivery–part 1
Acharya et al. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Meinel et al. Silk constructs for delivery of musculoskeletal therapeutics
KR20190107712A (ko) 특정 위장 부위에서의 제어 방출의 투여 형태
HK1213503A1 (zh) 药物递送医疗装置
JP2014111603A5 (enExample)
JP7636334B2 (ja) 治療物質の眼投与のための薬物送達組成物及びその使用法
MX2018001499A (es) Sistema para la entrega de polimeros liquidos para la administracion prolongada de farmacos.
MX383077B (es) Composiciones farmaceuticas para la administracion intraocular que comprenden un agente antibacteriano y un agente antiinflamatorio.
WO2018206749A1 (en) Ocular compositions
WO2016081616A3 (en) Transdermal patch formulations for delivery of water soluble drugs, peptides, proteins and oligosaccharides
WO2013039621A3 (en) Methods and systems for making microtablets for drug delivery
Tamaddon et al. Design and development of intraocular polymeric implant systems for long-term controlled-release of clindamycin phosphate for toxoplasmic retinochoroiditis
Park et al. Research progress on detachable microneedles for advanced applications
WO2014075203A8 (es) Nanopartículas con polímero biodegradable y biocompatible plga cargadas con el fármaco de uso humano pentoxfilina
Kulinsky et al. BioMEMs for drug delivery applications
Li et al. Microparticles